Authors’ instructions

Russian Open Medical Journal (RusOMJ) (ISSN 2304-3415) publishes peer-reviewed articles on all aspects of medicine, including original clinical studies, experimental investigations with clear clinical relevance, review papers, clinical guidelines and position papers, editorials, perspective articles, images in cardiovascular  medicine, letters and research letters to editor, and case reports. The interdisciplinary articles are also welcome.

We recommend that all manuscripts be submitted online (see page "Submit manuscript"). Manuscript submissions should conform to the guidelines set forth in the “Uniform Requirements for Manuscripts Submitted to Biomedical Journals: Writing and Editing for Biomedical Publication,” available from

If your work is of good quality and fits the journal scope, we welcome it for peer reviewing. If you decide to submit your paper, please ease our work by carefully adhering to our journal requirements. 

Note, final acceptance rate of submitted papers was 10% in 2021 year [see details].

Before sending manuscript for review to referees editor checks the adherence of the manuscript’s format to general guidelines. The spelling and grammar errors are required to be corrected before submission of manuscript. The revised versions of manuscripts should include incorporated revisions highlighted. Manuscripts that do not comply with Instructions to Authors will not undergo peer-review.


Description of Manuscripts Types

RusOMJ welcomes manuscripts in the following categories:

  • Original articles will provide detailed description of scientific findings within the scope of the journal. This type of articles should contain structured abstract (200-250 words), divided as Background-Objective-Methods and results-Conclusion or Aim-Material and Methods-Results-Conclusions, and up to five keywords. Original article should be organized following structure: Introduction, Material and Methods, Results, Discussion, Conclusions, Acknowledgments and References.
  • Review articles will be focused on a significantly important topics. This type of articles should contain unstructured abstract (100 – 150 words), up to five keywords and should incorporate a judicious use of tables, figures, schemes and references.
  • Authors' opinions will provide authors' position on a significantly important topics. Opinion maybe as hypotesis based on results of previous authors' research. This type of articles should contain unstructured abstract (100 – 150 words), up to five keywords.
  • Short reports will provide short description of results of clinical trials, healthcare projects, etc. This type of articles should contain structured or unstructured abstract (100 – 150 words), up to five keywords.
  • Public reports will provide detail description of results of clinical trials, healthcare projects, etc. This type of articles should contain structured or unstructured abstract (100 – 150 words), up to five keywords.
  • Research letters will be short version of a Original article. Manuscripts which announce a new scientific invention, are clinically significant, and are in the form of a preliminary report are accepted for publication as scientific letters. The discussion could be integrated in the same section with the results as 'Results and Discussion' section; 'Conclusions and Future Directions' are optional. This type of articles should contain structured or unstructured abstract (100 – 150 words), up to five keywords.
  • Case reports. Since a limited number of case reports is published, only reports which are related to rare cases and conditions that constitute challenges in diagnosis and treatment, offer new methods or suggest knowledge not included in books, and are interesting and educational are accepted for publication. This type of articles should contain unstructured abstract (100 – 150 words), up to five keywords. Main Text should include Introduction, Case Report, Discussion and Conclusion sections and should not exceed 1000 words excluding the references. The reference list should follow the main text and the number of references should be limited to 10. Tables and figures would be included. Video images (in English soundtrack) can be included. Case reports that include video images have a better chance of publication.
  • Trial designs. The RusOMJ publishes trial rationale and design papers (also known as "methods papers") for large cardiovascular clinical trials and registries.  Preference is given for large phase III randomized clinical trials, but the editors will consider well-designed registries and large phase II or phase IV studies. Authors should include the following sections: i) Brief trial summary (300 words); ii) Introduction - discussion of the trial rationale and prior relevant data. Include the trial hypotheses and objectives; iii) Methods - trial design (please include a figure of the trial schema), entry criteria, and statistical section that describes the key endpoints, power/sample size calculation, and major analytic plan; iv) Discussion - place your trial in the context of prior and ongoing trials, and the implications for future practice; v) Conclusion; vi) References. Publication of baseline characteristics and baseline data are encouraged, but not required. Appendices that list the trial organization, including major committees, countries, core laboratories, etc. may also be included.
  • Letter to the Editors. Letters to the Editor aim to discuss the importance of a manuscript previously published in Russian Open Medical Journal or other journals. This type of manuscripts should also include a comment on the published manuscript. Moreover, articles on topics of interest to readers within the scope of the journal, especially on educational issues, can be published in the format of a Letter to the Editor. This type of articles should contain unstructured abstract (100 – 150 words), up to five keywords. Main text should not include subheadings and it should be limited to 1000 words. The reference list should follow the main text and the number of references should be limited to 10. Tables, figures and images, and other visuals are not included.
  • Publication Ethics. These articles include current information on research and publication ethics and also cases of ethical violation. This type of articles should contain unstructured abstract (100 – 150 words), up to five keywords. Main text should not exceed 1000 words. The reference list should follow the main text and the number of references should be limited to 10. Tables and figures can be included.


Note! Original Investigations and Reviews should be presented according to the guidelines: randomized study – CONSORT, observational study – STROBE, study on diagnostic accuracy – STARD, systematic reviews and meta-analysis PRISMA, animal experimental studies – ARRIVE, nonrandomized behavioural and public health intervention studies – TREND, qualitative study - COREQ.


Authorship Criteria and Contributions and Authorship Form. Each author should have participated sufficiently in the work to take public responsibility for appropriate portions of the content. One or more authors should take responsibility for the integrity of the work as a whole, from inception to published article. Authorship credit should be based only on (1) substantial contributions to conception and design, or acquisition of data, or analysis and interpretation of data; and (2) drafting the article or revising it critically for important intellectual content; and (3) final approval of the version to be published.  

The authors also must certify that the manuscript represents valid work and that neither this manuscript nor one with substantially similar content under their authorship has been published or is being considered for publication elsewhere. Authors of manuscripts reporting original data or systematic reviews must provide an access to data statement from at least one named author, often the corresponding author If requested, authors should be prepared to provide the data and must cooperate fully in obtaining and providing the data on which the manuscript is based for examination by the editors or their assignees.

Authors cannot be added and/or removed from a manuscript once the paper is accepted for publication.

Role of the Corresponding Author. The corresponding author (or coauthor designee) will serve on behalf of all coauthors as the primary correspondent with the editorial office during the submission and review process. If the manuscript is accepted, the corresponding author will review an edited typescript and proof, make decisions regarding release of information in the manuscript to the news media, federal agencies, or both, and will be identified as the corresponding author in the published article. The corresponding author is responsible for ensuring that the Acknowledgment section of the manuscript is complete. “Acknowledgment” is the general term for the list of contributions, disclosures, credits, and other information included at the end of the text of a manuscript but before the references. The corresponding author is responsible for ensuring that the conflict of interest disclosures reported in the Acknowledgment section of the manuscript are accurate, up-to-date, and consistent with the information provided for each author. The corresponding author must sign the Authorship Form confirming that all persons who have contributed substantially are identified as authors and that written permission from each author has been obtained.

Conflicts of Interest. All authors must make a formal statement indicating any potential conflict of interest that might constitute an embarrassment to any of the authors if it were not to be declared and were to emerge after publication. Authors must state all possible conflicts of interest in the manuscript, including financial, consultant, institutional and other relationships that might lead to bias or a conflict of interest. If there is no conflict of interest, this should also be explicitly stated as none declared. All sources of funding should be acknowledged in the manuscript. 

Examples of potential conflicts of interests that are directly or indirectly related to the research may include but are not limited to the following:
  • Research grants from funding agencies (please give the research funder and the grant number)
  • Honoraria for speaking at symposia
  • Financial support for attending symposia
  • Financial support for educational programs
  • Employment or consultation
  • Support from a project sponsor
  • Position on advisory board or board of directors or other type of management relationships
  • Multiple affiliations
  • Financial relationships, for example equity ownership or investment interest
  • Intellectual property rights (e.g. patents, copyrights and royalties from such rights)
  • Holdings of spouse and/or children that may have financial interest in the work

In addition, interests that go beyond financial interests and compensation (non-financial interests) that may be important to readers should be disclosed. These may include but are not limited to personal relationships or competing interests directly or indirectly tied to this research, or professional interests or personal beliefs that may influence your research.

See below examples of disclosures: 
"Funding: This study was funded by X (grant number X)."
"Conflict of Interest: Author A has received research grants from Company A. Author B has received a speaker honorarium from Company X and owns stock in Company Y. Author C is a member of committee Z."
If no conflict exists, the authors should state:
"Conflict of Interest: The authors declare that they have no conflict of interest."
Statement of human rights. When reporting studies that involve human participants, authors should include a statement that the studies have been approved by the appropriate institutional and/or national research ethics committee and have been performed in accordance with the ethical standards as laid down in the 1964 Declaration of Helsinki and its later amendments or comparable ethical standards.
If doubt exists whether the research was conducted in accordance with the 1964 Helsinki Declaration or comparable standards, the authors must explain the reasons for their approach, and demonstrate that the independent ethics committee or institutional review board explicitly approved the doubtful aspects of the study.
The following statements should be included in the text before the References section:
"Ethical approval: All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.”
For retrospective studies, please add the following sentence: “For this type of study formal consent is not required.”
Statement on the welfare of animals. The welfare of animals used for research must be respected. When reporting experiments on animals, authors should indicate whether the international, national, and/or institutional guidelines for the care and use of animals have been followed, and that the studies have been approved by a research ethics committee at the institution or practice at which the studies were conducted (where such a committee exists).
For studies with animals, the following statement should be included in in the text before the References section: 
"Ethical approval: All applicable international, national, and/or institutional guidelines for the care and use of animals were followed."
If applicable (where such a committee exists): “All procedures performed in studies involving animals were in accordance with the ethical standards of the institution or practice at which the studies were conducted.”
If articles do not contain studies with human participants or animals by any of the authors, please select one of the following statements:
“This article does not contain any studies with human participants performed by any of the authors.”
“This article does not contain any studies with animals performed by any of the authors.”
“This article does not contain any studies with human participants or animals performed by any of the authors.”


Expedited Publication Decision

Have you completed an original study related to fundamental or clinical medicine and previously submitted for publication, but have yet to publish your work?

The editor of Russian Open Medical Journal is excited to announce a new policy that guarantees an “expedited publication decision” within 15 days of receipt of “original studies” that are submitted with a copy of an Editor's rejection letter, at least 2 peer reviews from a Journal with an impact factor of 1.5 (Web of Science) or greater, responses to the peer reviews, a highlighted copy of the paper in red indicating where the changes were made according to the reviewer concerns, and a non-highlighted copy of the paper.


Manuscript Preparation

The manuscript should be written in English (US/UK spell) in a clear, concise and precise style.

Please use the template file when preparing the manuscript.

Note, all abbreviations must be transcribed at first mention in the text.

The research articles (original articles, research letters) must be divided into the following sections:

  • Title: The title of the article should be precise and brief and must not be more than 15 words. Authors should avoid the use of abbreviations.
  • Title page: Title page should include paper title, author(s) full name and affiliation, corresponding author(s) names complete affiliation/address, along with phone, fax and email.
  • Abstract (Original articles): An abstract of maximum 250 words should be typed on a separate page in a form of a single paragraph and should be written in an informative style (purpose, basic methods, main results and principal conclusions). Abstract of original article should be divided as Background-Objective-Methods and results-Conclusion or Aim-Methods-Results-Conclusions. Abstract (Research letters): This type of articles should contain structured or unstructured abstract (100 – 150 words).
  • Keywords: he content of the paper should be characterized by at least 3 and not more that 5 keywords in English at the end of the abstract.
  • Introduction: Provide a context or background for the study (i.e., the nature of the problem and its significance). State the specific purpose or research objective of, or hypothesis tested by, the study or observation at the end of this section. Give only strictly pertinent references and do not include data or conclusions from the work being reported. References are numbered in the list in the order they first appear in the text.
  • Material and Methods:

The Methods section should include only information that was available at the time the plan or protocol for the study was written; all information obtained during the conduct of the study belongs in the Results section.

Technical information. Identify the methods, apparatus (give the manufacturer’s name and address in parentheses), and procedures in sufficient detail to allow other researchers to reproduce the study. Briefly describe for methods that have been published but are not well known (provide also the references). Describe in details new or substantially modified methods, give reasons for using them, and evaluate their limitations.

Statistics. Describe statistical methods with enough detail to enable a knowledgeable reader with access to the original data to verify the reported results. When possible, quantify findings and present them with appropriate indicators of measurement error or uncertainty (such as confidence intervals). Define statistical terms, abbreviations, and most symbols. Statistical analysis should be conducted in accordance with the guidelines on reporting statistical data in medical journals [Altman DG, Gore SM, Gardner MJ, Pocock SJ. Statistical guidelines for contributors to medical journals. Br Med J 1983: 7; 1489-93.; and Lang T, Altman D. Basic statistical reporting for articles published in clinical medical journals: the SAMPL Guidelines. In: Smart P, Maisonneuve H, Polderman A (editors). Science Editors’ Handbook, European Association of Science Editors, 2013.]. The software used for statistical analysis must be described. Data must be expressed as mean ± standard deviation when parametric tests are used to compare continuous variables. For non-parametric tests, data must be expressed as median (minimum-maximum) or percentiles (25th and 75th percentiles). In advanced and complex statistical analyses, relative risk (RR), odds ratio (OR) and hazard ratio (HR) must be supported by confidence intervals and P-values. The outcomes of statistical analyses and interpretation of the results must be in evidence-based scientific language [Editors of Heart Group journals. Statement on matching language to the type of evidence used in describing outcomes data.]. Other resources on "statistical analysis of medical data" can also be used for guidance.

  • Results: Present your results in logical sequence in the text, tables, and illustrations, giving the main or most important findings first. Do not repeat in the text all the data in the tables or illustrations; emphasize or summarize only important observations. Give numeric results not only as derivatives (for example, percentages) but also as the absolute numbers from which the derivatives were calculated, and specify the statistical methods used to analyze them. Restrict tables and figures to those needed to explain the argument of the paper and to assess its support. Use graphs as an alternative to tables with many entries; do not duplicate data in graphs and tables. Avoid non-technical uses of technical terms in statistics, such as “random” (which implies a randomizing device), “normal,” “significant,” “correlations,” and “sample.”
  • Discussion: Emphasize the new and important aspects of the study and the conclusions that follow from them. Do not repeat in detail data or other material given in the Introduction or the Results section. State new hypotheses when warranted, but clearly label them as such.
  • Conclusion(s): Link the conclusions with the goals of the study but avoid unqualified statements and conclusions not adequately supported by the data.
  • Ethical Issues: Provide clear statement on the ethical issues if clinical or animal research has been conducted if applied.  Institutional review board (IRB) approvals are required in Material amd Methods section for all submitted research articles

  • Conflicts of interest: Conflict of interest statement, patient confidentiality issues, and permissions. Where an author gives no conflict of interest, the listing will read 'The author(s) declare that they have no conflict of interest'.

  • Acknowledgements (if any): Please acknowledge anyone (individual/company/institution) who has contributed to the study by making substantial contributions to conception, design, acquisition of data, or analysis and interpretation of data, or who was involved in drafting the manuscript or revising it critically for important intellectual content. Please list the source(s) of funding for the study (if any), for each author, and for the manuscript preparation in the acknowledgements section.

  • References: All references should be numbered sequentially [in square brackets] in the text and listed in the same numerical order in the Reference section.

Do not cite personal communications, manuscripts in preparation or other unpublished data in the references; these may be cited in the text in parentheses. If letters to the editor are cited, identify them with the word "letter" in parentheses. Do not cite abstracts that are older than two years. Identify abstracts by the abbreviation "abstr" in parentheses.

Use Index Medicus (National Library of Medicine) abbreviations for journal titles.

For general guide about style and punctuation of references, we recommend use The NLM Style Guide for Authors, Editors, and Publishers (2nd edition).

Use the following style and punctuation for references:

  • Periodical: List all authors if six or fewer, otherwise list the first six and add the et al.; do not use periods after the authors' initials. Please provide inclusive page numbers as in example below.


  1. Chen LH, Xi S, Cohen DA. Liver Antioxidant defenses in mice fed ethanol and the AIN-76A Diet. Alcohol 1995; 12(5): 453-457 (doi: 10.1016/0741-8329(95)00030-U) (PMID: 8519441). Note: for all articles in References list, DOI and/or PMID must be indicated!
  2. Kim E, Han JY, Moon TJ, Shaw B, Shah DV, McTavish FM, Gustafson DH. The process and effect of supportive message expression and reception in online breast cancer support groups. Psychooncology. 2011 Mar 17. doi: 10.1002/pon.1942. (journal article online first)
  3. Lemanek K. Adherence issues in the medical management of asthma. J Pediatr Psychol [Internet]. 1990 [cited 2010 Apr 22];15(4):437-58. Available from: URL: /15/4/437. (electronic journal article)
  • Chapter in book: Provide inclusive page numbers, authors, chapter titles, book title, editor, publisher and year. Example: Meidell RS, Gerard RD, Sambrook JF. Molecular biology of thrombolytic agents. In: Roberts R, editor. Molecular Basis of Cardiology. Cambridge, MA: Blackwell Scientific Publications; 1993: 295–324.
  • Book (personal author or authors): Provide a specific (not inclusive) page number. Example: Cohn PF. Silent Myocardial Ischemia and Infarction. 3rd ed. New York, NY: Marcel Dekker; 1993:33.
  • Online Media: Provide specific URL address and date information was accessed. Example: Henkel J. Testicular Cancer: Survival High With Early Treatment. FDA Consumer magazine [serial online]. January–February 1996. Available at: Accessed August 31, 1998.
  • Conference paper: Example: Bolboacă S, Jäntschi L. Binomial distribution sample confidence intervals estimation for positive and negative likelihood ratio medical key parameters. AMIA Annu Symp Proc. 2005:66-70.


Tables. Number tables with Arabic numerals in the order in which they appear in the text, e.g. (Table 3). Use titles that concisely describe the content of the table so that a reader can understand the table without referring to the text. Tables may contain abbreviations that we do not permit in the text, but the table should contain a footnote that explains the abbreviation. Give the units of measure for all numerical data in a column or row. Place units of measure under a column heading or at the end of a side heading only if those units apply to all numerical data in the column or row.

Figures. References to figures and tables should be made in order of appearance in the text and should be in Arabic numerals in parentheses, e.g. (Fig. 2). Each figure should have a figure legend that begins with a short title. Reduce the length of legends by using phrases rather than sentences. Explain all abbreviations and symbols on the figure, even if an explanation appears in the text. For pictures of histologic slides, give stain and magnification data at the end of the legend for each part of the figure. If no scale marker appears on the figure, give the original magnification used during the observation, not that of the photographic print.

Most file formats are accepted, but PNG, JPEG, TIFF and EPS files, with fonts embedded, are preferred. If scanned, line art should be at a resolution of 800 dpi, and halftones and colour at 300 dpi. Colour illustrations are acceptable.

Electronic supplementary material. RusOMJ accepts electronic multimedia files (animations, movies, audio, etc.) and other supplementary files to be published online along with an article. Supply all supplementary material in standard file formats. To accommodate user downloads, please keep in mind that larger-sized files may require very long download times and that some users may experience other problems during downloading.

Audio, Video, and Animations:

  • Aspect ratio: 16:9 or 4:3
  • Maximum file size: 25 GB
  • Minimum video duration: 1 sec
  • Supported file formats: avi, wmv, mp4, mov, m2p, mp2, mpg, mpeg, flv, mxf, mts, m4v, 3gp

Text and Presentations:

  • Submit your material in PDF format; .doc or .ppt files are not suitable for long-term viability.
  • A collection of figures may also be combined in a PDF file.


Information about all co-authors. For each author of paper, the full name, title, position, subdivision, organization, city, country and ORCID must be presented at the end of the paper.

hcs777 hcs777 hcs777